[Bio-software] Adopting R&D Informatics Systems Conference: Deadline Friday

Jim Prudhomme via bio-soft%40net.bio.net (by jprudhomme from healthtech.com)
Mon Jan 4 16:11:49 EST 2010


**************************************************************
Register by January 8 and Save up to $200

 

Cambridge Healthtech Institute's Second Annual 
ADOPTING R&D INFORMATICS SYSTEMS

Data Management, Integration & Knowledge Management


February 3-5, 2010 
Moscone North Convention Center | San Francisco, CA

 

View details: www.tri-conference.com/ird.asp <http://www.Tri-Conference.com>

Register: https://chidb.com/register/2010/mmtc/reg.asp

**************************************************************

Featured Presentations

 

Recent Strategies with Cloud, Wikis, Ontologies and Open Source Data
Standards

Giles M. Day, Senior Director, BBC Informatics, Pfizer, Inc.

 

Enterprise Scientific Workflow Environment Drives Innovation

Juergen Hammer, Ph.D., M.B.A., Pharma Research Scientific Informatics;
Global Head, In Silico Sciences; Center Head,
Scientific Informatics, F. Hoffmann-La Roche, Inc.

 

Integrated Informatics Systems for R&D

John Reynders, Ph.D., CIO, Pharmaceutical Research & Development, Johnson &
Johnson 

The Pistoia Alliance, Inc. - A Construct for Precompetitive Collaboration

Chris Waller, Ph.D., Senior Director, Precompetitive Collaborations,
Research, Development & Medical Informatics, Worldwide Technology, Pfizer,
Inc. 

 

Executive Panel with Q&A

Are We Integrating the Right Data: Extending Beyond Laboratory Data to
Decisions Impacting Project Success

 

Moderator: David M. Sedlock, Ph.D., Senior Director, Research & Development
Systems, Millennium, The Takeda Oncology Company 

 

Thought-Leaders will Address

.         Executive Strategies - Integrated R&D Informatics

.          Data Information and Knowledge Management

.         Cloud, Wikis, Ontologies & Semantic Web

.         Translational Informatics

.         Integrated Genomic, Biology and  Image Data

 

Pre-Conference Short Courses*

 

(SC1) Applying Next Generation Sequencing Technologies to Research 

Introduction to New Technologies and Application in Research

 

(SC2) Best Practices in Translational & Personalized Medicine

 

*Separate registration is required. 

 

Distinguished Faculty

 

Jonas S. Almeida, Ph.D., Abell-Hanger Distinguished Professor,
Bioinformatics and Computational Biology, University of Texas, M.D. Anderson
Cancer Center

 

Arvindh Balakrishnan, Vice President Life Sciences, Oracle

 

Rob Brown, Ph.D., Senior Director, Informatics Marketing, Accelrys

 

Frank Brown, Ph.D., VP & CSO, Accelrys

 

Irina Antonijevic, M.D., Ph.D., Director, Translational Research, Biological
Research, Lundbeck Research, Inc. USA

 

Barry A. Bunin, Ph.D., Chief Executive Officer & President, Collaborative
Drug Discovery (CDD), Inc.

 

Jake Chen, Ph.D., Assistant Professor, Informatics & Computer Science,
Indiana University School of Informatics; Director, Indiana Center for
Systems Biology 

and Personalized Medicine, Indiana University-Purdue University
Indianapolis; Founder, MedeoLinx, Inc.

 

Randal Chen, Ph.D., Director, Research Informatics, Amgen, South San
Francisco

 

John F. Crowley, Founder, Novazyme Pharmaceuticals, Inc.

 

Giles M. Day, Senior Director, BBC Informatics, Pfizer, Inc.

 

Joe Duncan, Chief Executive Officer, Teranode

 

Juergen Hammer, Ph.D., M.B.A., Pharma Research Scientific Informatics;
Global Head, In Silico Sciences; Center Head, Scientific Informatics, F.
Hoffmann-La Roche, Inc.

 

Thomas P. Hill, Principal, The Leverage Innovation Group; former Director,
Learning and Knowledge Management, Genentech

 

David Hodgson, Ph.D., Site Head, Global Research Informatics, Roche Palo
Alto

 

Pearl S. Huang, Ph.D., Integrator, Oncology Franchise, Research & Early
Development, Merck & Co.

 

Jim Karkanias, Senior Director of Applied Research & Technology, Microsoft
Health Solutions Group

 

Michael Lajiness, Ph.D., Principal Research Scientist, Structural and
Computational Sciences, Eli Lilly & Company 

 

Man-Ling Lee, Ph.D., Senior Program Analyst, Discovery Chemistry, Small
Molecule Drug Discovery, Genentech, Inc.

 

David A. Medina, Worldwide Life Science and Pharma Segment Executive,
Hewlett-Packard CompanyN. R. Nirmala, Ph.D., Director, 

Biomarker Analysis and Informatics Unit, Translational Sciences, Novartis
Institutes of Biomedical Research 

 

Jeremy Packer, Ph.D., Head, Bioinformatics, Abbott

 

Adam Renslo, Ph.D., Associate Director, Chemistry, Adjunct Assistant
Professor, Pharmaceutical Chemistry, UCSF

 

John Reynders, Ph.D., CIO, Pharmaceutical Research & Development, Johnson &
Johnson 

 

Eric Schadt, Ph.D., Chief Scientific Officer, Pacific Biosciences

 

David M. Sedlock, Ph.D., Senior Director, Research & Development Systems,
Millennium, The Takeda Oncology Company 

 

Ajay Shah, Ph.D., MBA, PMP, Director, Research Informatics, Elan
Pharmaceuticals, Inc.

 

Paul J.H. Schoemaker, Ph.D., M.B.A., Chairman and Chief Executive Officer,
Decision Strategies International, Inc.; Research Director, Mack Center for 

Technological Innovation, The Wharton School; Adjunct Professor of
Marketing, The Wharton School Adjunct Professor, Wharton School of Business

 

Uli Schmitz, Ph.D., Director, Structural Chemistry, Gilead

 

Jonathan Sheldon, Ph.D., Director of Translational Medicine, IDBS

 

Matt Silva, Head, Imaging Sciences, Millennium, The Takeda Oncology Company

 

Gary W. Small, M.D., Parlow-Solomon Professor on Aging, Professor of
Psychiatry & Biobehavioral Sciences, Director, UCLA Center on Aging, 

Director, Memory & Aging Research Center, Director, Geriatric Psychiatry
Division, Semel Institute for Neuroscience & Human Behavior, 

David Geffen School of Medicine at UCLA

 

Susie Stephens, Director, Biomedical Informatics, Pharmaceutical Research &
Development, Johnson & Johnson

 

Chris Waller, Ph.D., Senior Director, Precompetitive Collaborations,
Research, Development & Medical Informatics, Worldwide Technology, Pfizer,
Inc.

 

W. Patrick Walters, Ph.D., Senior Research Fellow & Group Head,
Computational Drug Discovery Technologies, Vertex Pharmaceuticals, Inc.

 

Jian Wang, Ph.D., CEO, BioFortis Inc.

 

Sponsorship & Exhibit Information

 

Showcase your technologies, services, and solutions to this audience.  CHI
will work closely with you to shape a package that suits your company's
objectives and budget. 

 

For details, contact:

Carol Dinerstein

Director, Exhibit & Sponsorship Sales

Tel: 781-972-5471

dinerstein from healthtech.com

 

or

Jon Stroup

Manager, Business Development

Tel: 781-972-5483

jstroup from healthtech.com

 

Adopting R&D Informatics Systems is part of the Informatics Channel at CHI's
17th International Molecular Medicine Tri-Conference.

 

Register by January 8 and Save up to $200:
https://chidb.com/register/2010/mmtc/reg.asp

 

Questions or to register via telephone, contact:
Cambridge Healthtech Institute

250 First Avenue, Suite 300

Needham, MA 02494

Tel:  781-972-5400

Fax: 781-972-5425

www.healthtech.com

 

Posted by:  James Prudhomme

 



More information about the Bio-soft mailing list